Loading insider details...
Latest Form 4 (Jul 2, 2026): Grant/Award of 125,000 LCTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 125,000 | n/a |
| Jul 3, 2025 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 75,000 | n/a |
| Jul 3, 2024 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 75,000 | n/a |
| Jul 3, 2023 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 50,000 | n/a |
| Jul 6, 2022 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 50,000 | n/a |
| Mar 29, 2022 | Lineage Cell Therapeutics, Inc. (LCTX) | Purchase | 35,000 | $57.0K |
| Jul 1, 2021 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 50,000 | n/a |
| Apr 22, 2021 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/Award | 90,000 | n/a |